The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode
Abstract Background Hypoglycaemia has been shown to induce a systemic pro-inflammatory response, which may be driven, in part, by the adrenaline response. Prior exposure to hypoglycaemia attenuates counterregulatory hormone responses to subsequent hypoglycaemia, but whether this effect can be extrapolated to the pro-inflammatory response is unclear. Therefore, we investigated the effect of antecedent hypoglycaemia on inflammatory responses to subsequent hypoglycaemia in humans. Methods Healthy participants (n = 32) were recruited and randomised to two 2-h episodes of either hypoglycaemia or normoglycaemia on day 1, followed by a hyperinsulinaemic hypoglycaemic (2.8 ± 0.1 mmol/L) glucose clamp on day 2. During normoglycaemia and hypoglycaemia, and after 24 h, 72 h and 1 week, blood was drawn to determine circulating immune cell composition, phenotype and function, and 93 circulating inflammatory proteins including hs-CRP. Results In the group undergoing antecedent hypoglycaemia, the adrenaline response to next-day hypoglycaemia was lower compared to the control group (1.45 ± 1.24 vs 2.68 ± 1.41 nmol/l). In both groups, day 2 hypoglycaemia increased absolute numbers of circulating immune cells, of which lymphocytes and monocytes remained elevated for the whole week. Also, the proportion of pro-inflammatory CD16+-monocytes increased during hypoglycaemia. After ex vivo stimulation, monocytes released more TNF-α and IL-1β, and less IL-10 in response to hypoglycaemia, whereas levels of 19 circulating inflammatory proteins, including hs-CRP, increased for up to 1 week after the hypoglycaemic event. Most of the inflammatory responses were similar in the two groups, except the persistent pro-inflammatory protein changes were partly blunted in the group exposed to antecedent hypoglycaemia. We did not find a correlation between the adrenaline response and the inflammatory responses during hypoglycaemia. Conclusion Hypoglycaemia induces an acute and persistent pro-inflammatory response at multiple levels that occurs largely, but not completely, independent of prior exposure to hypoglycaemia. Clinical Trial information Clinicaltrials.gov no. NCT03976271 (registered 5 June 2019)..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Cardiovascular Diabetology - 23(2024), 1, Seite 13 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Clementine E. M. Verhulst [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Antecedent hypoglycaemia |
|---|
| doi: |
10.1186/s12933-023-02095-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ092192831 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ092192831 | ||
| 003 | DE-627 | ||
| 005 | 20240414094013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12933-023-02095-w |2 doi | |
| 035 | |a (DE-627)DOAJ092192831 | ||
| 035 | |a (DE-599)DOAJ99ba37f75dd342839a07a50a2f591ca6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Clementine E. M. Verhulst |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Hypoglycaemia has been shown to induce a systemic pro-inflammatory response, which may be driven, in part, by the adrenaline response. Prior exposure to hypoglycaemia attenuates counterregulatory hormone responses to subsequent hypoglycaemia, but whether this effect can be extrapolated to the pro-inflammatory response is unclear. Therefore, we investigated the effect of antecedent hypoglycaemia on inflammatory responses to subsequent hypoglycaemia in humans. Methods Healthy participants (n = 32) were recruited and randomised to two 2-h episodes of either hypoglycaemia or normoglycaemia on day 1, followed by a hyperinsulinaemic hypoglycaemic (2.8 ± 0.1 mmol/L) glucose clamp on day 2. During normoglycaemia and hypoglycaemia, and after 24 h, 72 h and 1 week, blood was drawn to determine circulating immune cell composition, phenotype and function, and 93 circulating inflammatory proteins including hs-CRP. Results In the group undergoing antecedent hypoglycaemia, the adrenaline response to next-day hypoglycaemia was lower compared to the control group (1.45 ± 1.24 vs 2.68 ± 1.41 nmol/l). In both groups, day 2 hypoglycaemia increased absolute numbers of circulating immune cells, of which lymphocytes and monocytes remained elevated for the whole week. Also, the proportion of pro-inflammatory CD16+-monocytes increased during hypoglycaemia. After ex vivo stimulation, monocytes released more TNF-α and IL-1β, and less IL-10 in response to hypoglycaemia, whereas levels of 19 circulating inflammatory proteins, including hs-CRP, increased for up to 1 week after the hypoglycaemic event. Most of the inflammatory responses were similar in the two groups, except the persistent pro-inflammatory protein changes were partly blunted in the group exposed to antecedent hypoglycaemia. We did not find a correlation between the adrenaline response and the inflammatory responses during hypoglycaemia. Conclusion Hypoglycaemia induces an acute and persistent pro-inflammatory response at multiple levels that occurs largely, but not completely, independent of prior exposure to hypoglycaemia. Clinical Trial information Clinicaltrials.gov no. NCT03976271 (registered 5 June 2019). | ||
| 650 | 4 | |a Antecedent hypoglycaemia | |
| 650 | 4 | |a Clamp | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Inflammatory responses | |
| 650 | 4 | |a Humans | |
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Julia I. P. van Heck |e verfasserin |4 aut | |
| 700 | 0 | |a Therese W. Fabricius |e verfasserin |4 aut | |
| 700 | 0 | |a Rinke Stienstra |e verfasserin |4 aut | |
| 700 | 0 | |a Steven Teerenstra |e verfasserin |4 aut | |
| 700 | 0 | |a Rory J. McCrimmon |e verfasserin |4 aut | |
| 700 | 0 | |a Cees J. Tack |e verfasserin |4 aut | |
| 700 | 0 | |a Ulrik Pedersen-Bjergaard |e verfasserin |4 aut | |
| 700 | 0 | |a Bastiaan E. de Galan |e verfasserin |4 aut | |
| 700 | 0 | |a the Hypo-RESOLVE consortium |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Cardiovascular Diabetology |d BMC, 2003 |g 23(2024), 1, Seite 13 |w (DE-627)DOAJ000133507 |x 14752840 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2024 |g number:1 |g pages:13 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12933-023-02095-w |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/99ba37f75dd342839a07a50a2f591ca6 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12933-023-02095-w |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1475-2840 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2024 |e 1 |h 13 | ||